What stocks does Nippon India Pharma Fund hold?

Nippon India Pharma Fund holds a portfolio of Indian equity stocks disclosed monthly by Nippon India Mutual Fund to AMFI. The complete current holdings with weights and month-over-month changes are available on this page. Data is sourced from official AMFI portfolio disclosures.

Which AMC manages Nippon India Pharma Fund?

Nippon India Pharma Fund is managed by Nippon India Mutual Fund, a SEBI-registered Asset Management Company in India.

What category is Nippon India Pharma Fund?

Nippon India Pharma Fund is classified as a Equity mutual fund under SEBI's mutual fund categorisation framework.

How often is Nippon India Pharma Fund portfolio data updated?

Portfolio holdings for Nippon India Pharma Fund are updated monthly. SEBI mandates all AMCs to disclose their complete portfolio within 10 days of each month end. RightAdvise sources this data directly from official AMFI portfolio disclosures.

← Nippon India Mutual Fund

Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option

Equity Data as of Jun 2026 Comparing May 2026 → Jun 2026

Share: WhatsApp X

Stocks Held

Jun 2026

Equity Holdings

₹8,828.37 Cr

Equity only, excl. debt & cash

Top 5 Weight

38.5%

Moderate

Top 10 Weight

58.1%

Moderate

Changes

1 new · 0 exits

Top Sector

Pharmaceuticals & Biotechnology

72.5% of portfolio

📋 What Happened This Month Nippon India Pharma Fund added 1 new stock to its portfolio this month. The biggest new buy was Piramal Pharma Limited (Pharmaceuticals & Biotechnology) at 1.02% weight. Among existing holdings, Max Healthcare Institute Limited saw the biggest increase — now at 3.32% of the portfolio. Sun Pharmaceutical Industries Limited was trimmed the most, now at 12.78%. Sun Pharmaceutical Industries Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 72.5%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.

How Has the NAV Performed?

1 year history · Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option

+5.35%

+12.46%

+13.25%

+8.68%

Latest NAV

₹634.41

14 Jul 2026

52W High

₹634.56

-0% from High

52W Low

₹501.48

+27% from Low

Calendar Year Returns

Jan 1 to Dec 31 each year. Simple point-to-point — not CAGR.

2025

-2.5%

2024

+35.3%

2023

+40.4%

2022

-9.1%

2021

+25.1%

2020

+67.9%

2019

+2.5%

2018

+4.6%

2017

+8.6%

Rolling Returns

Performance across every possible investment start date.

1Y Rolling Avg

18.5%

+ve in 74% windows

88.4% / -14.9%

3Y Rolling Avg

19.3% p.a.

+ve in 99% windows

33.5% / -1.6%

5Y Rolling Avg

20.3% p.a.

+ve in 100% windows

32.2% / 12.3%

Crisis Period Behaviour

"Pre-inception" = fund didn't exist during that period.

2024–25 Tariff

-14.7%

Rec: Jul 2025 (7 mo)

COVID-19 Crash

-21.2%

Rec: Apr 2020 (1 mo)

2022 Rate Hike

-16.1%

Rec: Jun 2023 (1yr 5mo)

2018 IL&FS

-11.3%

Rec: Feb 2020 (1yr 11mo)

Risk Ratios

3 years daily NAV · Risk-free rate 6.5% p.a. What do these mean? →

Sharpe Ratio (3Y)

1.40

Return per unit of risk. >1 is good.

Sortino Ratio (3Y)

2.09

Penalises downside volatility only.

Std Deviation (3Y)

13.0%

Lower = more consistent returns.

NAV Chart ₹634.41 14 Jul 2026

Simple Moving Avg: Click to draw · click again to remove

Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option

Chart shows indexed performance (base = 100). Actual NAV: ₹634.41

Sector Shift Industry allocation month-over-month

Apr 2026 → May 2026

Sector	Prev	Curr ▼	Delta
Pharmaceuticals & Biotechnology	73.6%	72.4%	▼ -1.2%
Healthcare Services	21.3%	21.9%	▲ +0.6%
Retailing	3.8%	3.7%	▼ -0.1%

May 2026 → Jun 2026

Sector	Prev	Curr ▼	Delta
Pharmaceuticals & Biotechnology	72.4%	72.5%	● +0.1%
Healthcare Services	21.9%	22.0%	● +0.1%
Retailing	3.7%	3.2%	▼ -0.5%

🟢

Biggest New Buy

Piramal Pharma Limited

1.02% weight · Pharmaceuticals & Biotechnology

↑

Biggest Add

Max Healthcare Institute Limited

+0.35% · now 3.32%

↓

Biggest Trim

Sun Pharmaceutical Industries Limited

-0.57% · now 12.78%

🤝 Other funds also bought this month

Piramal Pharma Limited 4 funds

What Changed in the Portfolio This Month?

Comparing May 2026 → Jun 2026

May 2026 → Jun 2026

🟢 1 New Entry ↑ 16 Increased ↓ 18 Decreased

#	Stock	Sector	Weight (Jun 2026)
1	Piramal Pharma Limited ₹92.45 Cr	Pharmaceuticals & Biotechnology	1.02%

#	Stock	Sector	May 2026	Jun 2026	Change
1	Max Healthcare Institute Limited ₹300.16 Cr	Healthcare Services	2.97%	3.32%	+0.35%
2	Ajanta Pharma Limited ₹312.81 Cr	Pharmaceuticals & Biotechnology	3.21%	3.46%	+0.25%
3	Fortis Healthcare Limited ₹128.82 Cr	Healthcare Services	1.19%	1.42%	+0.23%
4	IPCA Laboratories Limited ₹232.14 Cr	Pharmaceuticals & Biotechnology	2.41%	2.57%	+0.16%
5	Lupin Limited ₹673.45 Cr	Pharmaceuticals & Biotechnology	7.31%	7.45%	+0.14%
6	GlaxoSmithKline Pharmaceuticals Limited ₹223.77 Cr	Pharmaceuticals & Biotechnology	2.34%	2.47%	+0.13%
7	Gland Pharma Limited ₹199.74 Cr	Pharmaceuticals & Biotechnology	2.09%	2.21%	+0.12%
8	Akums Drugs and Pharmaceuticals Limited ₹92.81 Cr	Pharmaceuticals & Biotechnology	0.92%	1.03%	+0.11%
9	Mankind Pharma Limited ₹364.33 Cr	Pharmaceuticals & Biotechnology	3.94%	4.03%	+0.09%
10	Thyrocare Technologies Limited ₹239.87 Cr	Healthcare Services	2.56%	2.65%	+0.09%
11	Apollo Hospitals Enterprise Limited ₹476.46 Cr	Healthcare Services	5.20%	5.27%	+0.07%
12	Sai Life Sciences Limited ₹315.46 Cr	Pharmaceuticals & Biotechnology	3.43%	3.49%	+0.06%
13	Emcure Pharmaceuticals Limited ₹137.03 Cr	Pharmaceuticals & Biotechnology	1.47%	1.52%	+0.05%
14	Sanofi India Limited ₹78.44 Cr	Pharmaceuticals & Biotechnology	0.83%	0.87%	+0.04%
15	Indoco Remedies Ltd ₹43.90 Cr	Pharmaceuticals & Biotechnology	0.45%	0.49%	+0.04%
16	Concord Biotech Limited ₹14.30 Cr	Pharmaceuticals & Biotechnology	0.14%	0.16%	+0.02%

#	Stock	Sector	May 2026	Jun 2026	Change
1	Sun Pharmaceutical Industries Limited ₹1,155.93 Cr	Pharmaceuticals & Biotechnology	13.35%	12.78%	-0.57%
2	Aurobindo Pharma Limited ₹158.29 Cr	Pharmaceuticals & Biotechnology	2.32%	1.75%	-0.57%
3	MedPlus Health Services Limited ₹287.43 Cr	Retailing	3.68%	3.18%	-0.50%
4	Vijaya Diagnostic Centre Limited ₹253.16 Cr	Healthcare Services	3.21%	2.80%	-0.41%
5	Divi's Laboratories Limited ₹493.92 Cr	Pharmaceuticals & Biotechnology	5.80%	5.46%	-0.34%
6	Abbott India Limited ₹189.12 Cr	Pharmaceuticals & Biotechnology	2.31%	2.09%	-0.22%
7	Pfizer Limited ₹141.28 Cr	Pharmaceuticals & Biotechnology	1.69%	1.56%	-0.13%
8	Suraksha Diagnostic Ltd ₹106.35 Cr	Healthcare Services	1.29%	1.18%	-0.11%
9	Syngene International Limited ₹153.89 Cr	Healthcare Services	1.79%	1.70%	-0.09%
10	Alkem Laboratories Limited ₹180.29 Cr	Pharmaceuticals & Biotechnology	2.06%	1.99%	-0.07%
11	AstraZeneca Pharma India Limited ₹51.47 Cr	Pharmaceuticals & Biotechnology	0.63%	0.57%	-0.06%
12	Dr. Lal Path Labs Limited ₹167.62 Cr	Healthcare Services	1.90%	1.85%	-0.05%
13	SANOFI CONSUMER HEALTHCARE ₹98.22 Cr	Pharmaceuticals & Biotechnology	1.14%	1.09%	-0.05%
14	Biocon Limited ₹61.46 Cr	Pharmaceuticals & Biotechnology	0.73%	0.68%	-0.05%
15	Dr. Reddy's Laboratories Limited ₹603.88 Cr	Pharmaceuticals & Biotechnology	6.72%	6.68%	-0.04%
16	Anthem Biosciences Limited ₹81.56 Cr	Pharmaceuticals & Biotechnology	0.93%	0.90%	-0.03%
17	Cipla Limited ₹556.13 Cr	Pharmaceuticals & Biotechnology	6.16%	6.15%	-0.01%
18	Narayana Hrudayalaya Limited ₹162.45 Cr	Healthcare Services	1.81%	1.80%	-0.01%

What Stocks Does This Fund Hold?

35 stocks — Jun 2026

#	Stock	Sector	Weight & Value
1	Sun Pharmaceutical Industries Limited ₹1,155.93 Cr	Pharmaceuticals & Biotechnology	12.78%
2	Lupin Limited ₹673.45 Cr	Pharmaceuticals & Biotechnology	7.45%
3	Dr. Reddy's Laboratories Limited ₹603.88 Cr	Pharmaceuticals & Biotechnology	6.68%
4	Cipla Limited ₹556.13 Cr	Pharmaceuticals & Biotechnology	6.15%
5	Divi's Laboratories Limited ₹493.92 Cr	Pharmaceuticals & Biotechnology	5.46%
6	Apollo Hospitals Enterprise Limited ₹476.46 Cr	Healthcare Services	5.27%
7	Mankind Pharma Limited ₹364.33 Cr	Pharmaceuticals & Biotechnology	4.03%
8	Sai Life Sciences Limited ₹315.46 Cr	Pharmaceuticals & Biotechnology	3.49%
9	Ajanta Pharma Limited ₹312.81 Cr	Pharmaceuticals & Biotechnology	3.46%
10	Max Healthcare Institute Limited ₹300.16 Cr	Healthcare Services	3.32%
11	MedPlus Health Services Limited ₹287.43 Cr	Retailing	3.18%
12	Vijaya Diagnostic Centre Limited ₹253.16 Cr	Healthcare Services	2.80%
13	Thyrocare Technologies Limited ₹239.87 Cr	Healthcare Services	2.65%
14	IPCA Laboratories Limited ₹232.14 Cr	Pharmaceuticals & Biotechnology	2.57%
15	GlaxoSmithKline Pharmaceuticals Limited ₹223.77 Cr	Pharmaceuticals & Biotechnology	2.47%
16	Gland Pharma Limited ₹199.74 Cr	Pharmaceuticals & Biotechnology	2.21%
17	Abbott India Limited ₹189.12 Cr	Pharmaceuticals & Biotechnology	2.09%
18	Alkem Laboratories Limited ₹180.29 Cr	Pharmaceuticals & Biotechnology	1.99%
19	Dr. Lal Path Labs Limited ₹167.62 Cr	Healthcare Services	1.85%
20	Narayana Hrudayalaya Limited ₹162.45 Cr	Healthcare Services	1.80%
21	Aurobindo Pharma Limited ₹158.29 Cr	Pharmaceuticals & Biotechnology	1.75%
22	Syngene International Limited ₹153.89 Cr	Healthcare Services	1.70%
23	Pfizer Limited ₹141.28 Cr	Pharmaceuticals & Biotechnology	1.56%
24	Emcure Pharmaceuticals Limited ₹137.03 Cr	Pharmaceuticals & Biotechnology	1.52%
25	Fortis Healthcare Limited ₹128.82 Cr	Healthcare Services	1.42%
26	Suraksha Diagnostic Ltd ₹106.35 Cr	Healthcare Services	1.18%
27	SANOFI CONSUMER HEALTHCARE ₹98.22 Cr	Pharmaceuticals & Biotechnology	1.09%
28	Akums Drugs and Pharmaceuticals Limited ₹92.81 Cr	Pharmaceuticals & Biotechnology	1.03%
29	Piramal Pharma Limited ₹92.45 Cr	Pharmaceuticals & Biotechnology	1.02%
30	Anthem Biosciences Limited ₹81.56 Cr	Pharmaceuticals & Biotechnology	0.90%
31	Sanofi India Limited ₹78.44 Cr	Pharmaceuticals & Biotechnology	0.87%
32	Biocon Limited ₹61.46 Cr	Pharmaceuticals & Biotechnology	0.68%
33	AstraZeneca Pharma India Limited ₹51.47 Cr	Pharmaceuticals & Biotechnology	0.57%
34	Indoco Remedies Ltd ₹43.90 Cr	Pharmaceuticals & Biotechnology	0.49%
35	Concord Biotech Limited ₹14.30 Cr	Pharmaceuticals & Biotechnology	0.16%